News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

Endocan, miR-221 predict development of diabetic neuropathy
09 Jan 2026
byStephen Padilla
Endocan and miR-221 expression levels are significantly associated with development of neuropathy in patients with diabetes, indicating their potential role as biomarkers to diagnose diabetic peripheral neuropathy (DPN) at an early stage before the development of clinical manifestations, reports a study presented at ATTD-Asia 2025.
09 Jan 2026

Tirzepatide delivers real-world benefits, safety in T2D patients in India
08 Jan 2026
byStephen Padilla
A real-world assessment of tirzepatide in Indian clinical practice has shown significant glycaemic and weight benefits in adults with type 2 diabetes (T2D). The medication is also well tolerated, with manageable gastrointestinal side effects, and highly accepted by patients.
08 Jan 2026






